{
    "id": "New-v26-a8b2c3d4-e5f6-4789-9012-34567890abcd",
    "type": "multipleChoice",
    "stem": "The nurse is caring for a patient, Mrs. Emily Carter, who is 12 hours postpartum after a vaginal delivery. Based on the provided patient data, which interventions are MOST appropriate for the nurse to implement?",
    "scoring": {
        "method": "dichotomous",
        "maxPoints": 1
    },
    "itemContext": {
        "patient": {
            "name": "Emily Carter",
            "age": 32,
            "gender": "Female",
            "iso": "Postpartum Unit",
            "allergies": [
                "Sulfa Drugs"
            ],
            "airborneCondition": false,
            "isolationSetToAirborne": false
        },
        "sbar": "S: Emily Carter, age 32, G2P2, vaginal delivery 12 hours ago. She had preeclampsia during pregnancy, managed with Magnesium Sulfate, which was discontinued 2 hours postpartum. B/P now 162/98. \nB: History of preeclampsia, no other significant medical history. Magnesium Sulfate was stopped at 04:00. Received Pitocin during labor and delivery. EBL was estimated at 600 mL.\nA: Currently, patient reports a headache rated 6/10, blurred vision. Fundus is firm, 2 cm above the umbilicus, and slightly deviated to the right. Lochia rubra, moderate amount with small clots. Vital signs at 06:00: T 37.1Â°C, HR 92 bpm, RR 18, BP 162/98, SpO2 98% on room air. Urinary output since delivery is 150 mL. Pt voided 50 mL at 05:30.\nR: I am concerned about possible postpartum preeclampsia exacerbation and urinary retention. Requesting orders for lab work (CMP, CBC, Urine Protein), catheterization if unable to void, and antihypertensive medication if BP remains elevated.",
        "tabs": [
            {
                "id": "labs",
                "title": "Labs",
                "content": "<table><thead><tr><th>Lab</th><th>Value</th><th>Normal Range</th></tr></thead><tbody><tr><td>Hemoglobin</td><td>10.8 g/dL</td><td>12-16 g/dL</td></tr><tr><td>Platelets</td><td>140,000/mcL</td><td>150,000-400,000/mcL</td></tr><tr><td>Uric Acid</td><td>7.8 mg/dL</td><td>2.4-6.0 mg/dL</td></tr><tr><td>Creatinine</td><td>1.1 mg/dL</td><td>0.5-1.0 mg/dL</td></tr><tr><td>AST</td><td>35 U/L</td><td>10-40 U/L</td></tr><tr><td>ALT</td><td>40 U/L</td><td>7-35 U/L</td></tr><tr><td>Urine Protein</td><td>+2</td><td>Negative</td></tr></tbody></table>"
            },
            {
                "id": "mar",
                "title": "MAR",
                "content": "<table><thead><tr><th>Medication</th><th>Dosage</th><th>Route</th><th>Frequency</th><th>Last Administered</th></tr></thead><tbody><tr><td>Acetaminophen</td><td>650 mg</td><td>PO</td><td>q4h PRN headache</td><td>02:00</td></tr><tr><td>Oxycodone</td><td>5 mg</td><td>PO</td><td>q4h PRN pain</td><td>02:00</td></tr><tr><td>Rho(D) Immune Globulin</td><td>300 mcg</td><td>IM</td><td>Once</td><td>05:00</td></tr><tr><td>Docusate Sodium</td><td>100 mg</td><td>PO</td><td>BID</td><td>06:00</td></tr></tbody></table>"
            },
            {
                "id": "vitals",
                "title": "Vitals",
                "content": "<table><thead><tr><th>Time</th><th>BP</th><th>HR</th><th>RR</th><th>SpO2</th><th>Temp</th></tr></thead><tbody><tr><td>02:00</td><td>150/92</td><td>88</td><td>16</td><td>99%</td><td>37.0</td></tr><tr><td>04:00</td><td>158/96</td><td>90</td><td>18</td><td>98%</td><td>37.1</td></tr><tr><td>06:00</td><td>162/98</td><td>92</td><td>18</td><td>98%</td><td>37.1</td></tr></tbody></table>"
            }
        ]
    },
    "pedagogy": {
        "bloomLevel": "Analyze",
        "cjmmStep": "Implement",
        "nclexCategory": "Physiological Integrity",
        "difficulty": 5,
        "topicTags": [
            "Maternal: Preeclampsia & Postpartum Hemorrhage"
        ]
    },
    "rationale": {
        "correct": "Monitoring blood pressure closely is crucial due to the risk of postpartum preeclampsia exacerbation. Hypertension needs to be promptly addressed to prevent complications like stroke or seizures. Catheterizing the patient is appropriate to relieve urinary retention, which can be caused by postpartum edema or medication effects. Accurate output measurement is important for assessing kidney function and fluid balance, especially in the context of preeclampsia.",
        "incorrect": "Administering Methylergonovine is contraindicated in patients with hypertension and preeclampsia as it can further elevate blood pressure, potentially leading to a hypertensive crisis. Encouraging ambulation is generally beneficial postpartum, but in this case, the patient's blurred vision and elevated blood pressure increase the risk of falls, making it unsafe without further assessment and stabilization. Continuing Magnesium Sulfate is not indicated as it was discontinued 2 hours prior and the patient is demonstrating signs of worsening hypertension, potentially masking symptoms.",
        "clinicalPearls": [
            "Postpartum preeclampsia can occur up to 6 weeks after delivery.",
            "Urinary retention is common postpartum and can exacerbate other complications.",
            "Magnesium Sulfate is typically discontinued postpartum, but close monitoring for preeclampsia symptoms is vital."
        ],
        "questionTrap": {
            "trap": "The question trap is to assume that since the patient is postpartum and Magnesium Sulfate was discontinued, the preeclampsia risk is gone. Also, the question might trick one into thinking that the patient needs a uterotonic.",
            "howToOvercome": "Recognize the signs of postpartum preeclampsia exacerbation (elevated BP, headache, blurred vision) and prioritize interventions that address the immediate risks of hypertension and urinary retention. Remember that postpartum preeclampsia can occur even after delivery."
        },
        "mnemonic": {
            "title": "POST-BIRTH",
            "expansion": "Pain in chest, Obstructed breathing/SOB, Seizures, Thoughts of hurting yourself or baby, Bleeding (soaking through one pad/hour), Incision not healing, Red or swollen leg, Temperature of 100.4F or higher, Headache that doesn't get better, or vision changes"
        }
    },
    "options": [
        {
            "key": "a",
            "label": "Administer Methylergonovine (Methergine) 0.2 mg IM.",
            "isCorrect": false
        },
        {
            "key": "b",
            "label": "Monitor blood pressure closely and report significant elevations.",
            "isCorrect": true
        },
        {
            "key": "c",
            "label": "Encourage ambulation to promote circulation and bladder emptying.",
            "isCorrect": false
        },
        {
            "key": "d",
            "label": "Catheterize the patient to measure residual urine volume.",
            "isCorrect": true
        },
        {
            "key": "e",
            "label": "Continue Magnesium Sulfate infusion at the previous rate.",
            "isCorrect": false
        }
    ]
}